It is thus possible that the observed differences in immune cell composition could be due to heterogeneity and molecular changes inherent in the human CRC samples and underscore the potential of the TME to influence the infiltration of diverse GPR15+ immune cells. The gene discussed is GPR15; the disease is colorectal carcinoma.